Login Register Cart 0
Generic placeholder image

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Meta-Analysis

A Meta-analysis of Randomized Controlled Trials of the Effect of Probiotic Food or Supplement on Glycemic Response and Body Mass Index in Patients with Type 2 Diabetes, Updating the Evidence

Author(s): Mohammad Asghari Jafarabadi, Azadeh Dehghani, Leila Khalili*, Ali Barzegar, Mahdi Mesrizad and Tohid Hassanalilou

Volume 17, Issue 3, 2021

Published on: 12 August, 2020

Page: [356 - 364] Pages: 9

DOI: 10.2174/1573399816666200812151029

Price: $65

Abstract

Background: To investigate the effects of probiotics on glucose metabolism and body mass index (BMI), and compare the efficacy of probiotic food with the probiotic supplement in patients with type 2 diabetes mellitus using a meta-analysis of randomized, controlled trials.

Methods: Online databases Embase, Web of Science, and PubMed were searched until November 2019 to identify eligible articles. Fourteen trials were included.

Results: Probiotic consumption reduced fasting plasma glucose (FPG) (SMD=-0.38, 95% CI: -0.76 to 0.01), glycosylated hemoglobin (HbA1c) (SMD=-0.64, 95% CI: -0.91 to -0.38), fasting insulin concentration (SMD=-0.48, 95% CI, -0.81 to -0.15), HOMA-IR (SMD=-1.01, 95% CI, -1.51 to -0.52), and BMI (SMD=-0.02, 95%CI, -0.17 to 0.13) in intervention groups compared with control groups. Subgroup analysis was conducted to trials with probiotic foods and probiotic supplements. Both of probiotic foods (SMD: -0.65, 95% CI: -1.04 to -0.26; SMD: -1.17, 95% CI: -2.14 to -0.20, respectively) and supplements (SMD: -0.64, 95% CI: -1.01 to -0.27; SMD: -0.98, 95% CI: -1.55 to -0.40, respectively) made significant reduction in HbA1c and HOMA.IR. Meta-analysis of trials with probiotic foods found non-significant changes in FBG and fasting insulin concentration (SMD: 0.11, 95% CI: -0.52 to 0.75; SMD: -0.14, 95% CI: -0.48 to 0.20, respectively); however the changes in trials with probiotic supplements were significant (SMD: -0.73, 95% CI: -1.22 to -0.23; SMD: -0.57, 95% CI: -0.97 to -0.17, respectively). Probiotic foods cause a non-significant raise in BMI (SMD: 0.23, 95% CI: -0.03 to 0.49); however, meta-analysis of trials with probiotic supplements found a non-significant reduction in BMI (SMD: -0.13, 95% CI: -0.31 to 0.04).

Conclusion: The present meta-analysis suggests that consuming probiotics could improve glucose metabolism and affect body weight, with a potentially greater effect when probiotics are used as supplements.

Keywords: Meta-analysis, probiotics, diabetes, BMI, insulin resistance, HbA1c.

[1]
Khalili L, Alipour B, Asghari JM, Hassanalilou T, Mesgari Abbasi M, Faraji I. Probiotic assisted weight management as a main factor for glycemic control in patients with type 2 diabetes: A randomized controlled trial. Diabetol Metab Syndr 2019; 11: 5.
[http://dx.doi.org/10.1186/s13098-019-0400-7 ] [PMID: 30675190]
[2]
Hassanalilou T, Payahoo L, Shahabi P, et al. The protective effects of Morus nigra L. leaves on the kidney function tests and histological structures in streptozotocin-induced diabetic rats. Biomed Res (Aligarh) 2017; 28.
[3]
International Diabetes Federation (IDF). The global picture 2017.
[4]
Rad AH, Abbasalizadeh S, Vazifekhah S, et al. The future of diabetes management by healthy probiotic microorganisms. Curr Diabetes Rev 2017; 13(6): 582-9.
[http://dx.doi.org/10.2174/1573399812666161014112515 ] [PMID: 27758705]
[5]
Bastani P, Akbarzadeh F, Homayouni A, et al. Health benefits of probiotic consumption Microbes in food and health. Springer 2016; pp. 163-83.
[6]
Kobyliak N, Conte C, Cammarota G, et al. Probiotics in prevention and treatment of obesity: A critical view. Nutr Metab (Lond) 2016; 13: 14.
[http://dx.doi.org/10.1186/s12986-016-0067-0 ] [PMID: 26900391]
[7]
Al-Salami H, Butt G, Fawcett JP, Tucker IG, Golocorbin-Kon S, Mikov M. Probiotic treatment reduces blood glucose levels and increases systemic absorption of gliclazide in diabetic rats. Eur J Drug Metab Pharmacokinet 2008; 33(2): 101-6.
[http://dx.doi.org/10.1007/BF03191026 ] [PMID: 18777945]
[8]
Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition 2012; 28(5): 539-43.
[http://dx.doi.org/10.1016/j.nut.2011.08.013 ] [PMID: 22129852]
[9]
Tonucci LB, Olbrich Dos Santos KM, Licursi de Oliveira L, Rocha Ribeiro SM, Duarte Martino HS. Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. Clin Nutr 2017; 36(1): 85-92.
[http://dx.doi.org/10.1016/j.clnu.2015.11.011 ] [PMID: 26732026]
[10]
Ostadrahimi A, Taghizadeh A, Mobasseri M, et al. Effect of probiotic fermented milk (kefir) on glycemic control and lipid profile in type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. Iran J Public Health 2015; 44(2): 228-37.
[PMID: 25905057]
[11]
Tajadadi-Ebrahimi M, Bahmani F, Shakeri H, et al. Effects of daily consumption of synbiotic bread on insulin metabolism and serum high-sensitivity C-reactive protein among diabetic patients: a double-blind, randomized, controlled clinical trial. Ann Nutr Metab 2014; 65(1): 34-41.
[http://dx.doi.org/10.1159/000365153 ] [PMID: 25196301]
[12]
Mohamadshahi M, Veissi M, Haidari F, Shahbazian H, Kaydani GA, Mohammadi F. Effects of probiotic yogurt consumption on inflammatory biomarkers in patients with type 2 diabetes. Bioimpacts 2014; 4(2): 83-8.
[PMID: 25035851]
[13]
Sato J, Kanazawa A, Azuma K, et al. Probiotic reduces bacterial translocation in type 2 diabetes mellitus: A randomised controlled study. Sci Rep 2017; 7(1): 12115.
[http://dx.doi.org/10.1038/s41598-017-12535-9 ] [PMID: 28935921]
[14]
Rezaei M, Sanagoo A, Jouybari L, et al. The effect of probiotic yogurt on blood glucose and cardiovascular biomarkers in patients with type II diabetes: A randomized controlled trial. Evid Based Care 2017; 6: 26-35.
[15]
Asemi Z, Zare Z, Shakeri H, Sabihi SS, Esmaillzadeh A. Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes. Ann Nutr Metab 2013; 63(1-2): 1-9.
[http://dx.doi.org/10.1159/000349922 ] [PMID: 23899653]
[16]
Firouzi S, Majid HA, Ismail A, Kamaruddin NA, Barakatun-Nisak MY. Effect of multi-strain probiotics (multi-strain microbial cell preparation) on glycemic control and other diabetes-related outcomes in people with type 2 diabetes: A randomized controlled trial. Eur J Nutr 2017; 56(4): 1535-50.
[http://dx.doi.org/10.1007/s00394-016-1199-8 ] [PMID: 26988693]
[17]
Sabico S, Al-Mashharawi A, Al-Daghri NM, et al. Effects of a multi-strain probiotic supplement for 12 weeks in circulating endotoxin levels and cardiometabolic profiles of medication naïve T2DM patients: A randomized clinical trial. J Transl Med 2017; 15(1): 249.
[http://dx.doi.org/10.1186/s12967-017-1354-x ] [PMID: 29228964]
[18]
Soleimani A, Zarrati Mojarrad M, Bahmani F, et al. Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects. Kidney Int 2017; 91(2): 435-42.
[http://dx.doi.org/10.1016/j.kint.2016.09.040 ] [PMID: 27927601]
[19]
Hsieh M-C, Tsai W-H, Jheng Y-P, et al. The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial. Sci Rep 2018; 8(1): 16791.
[http://dx.doi.org/10.1038/s41598-018-35014-1 ] [PMID: 30429496]
[20]
Razmpoosh E, Javadi A, Ejtahed HS, Mirmiran P, Javadi M, Yousefinejad A. The effect of probiotic supplementation on glycemic control and lipid profile in patients with type 2 diabetes: A randomized placebo controlled trial. Diabetes Metab Syndr 2019; 13(1): 175-82.
[http://dx.doi.org/10.1016/j.dsx.2018.08.008 ] [PMID: 30641692]
[21]
Forbes JD, Azad MB, Vehling L, et al. Canadian Healthy Infant Longitudinal Development (CHILD) Study Investigators. Association of exposure to formula in the hospital and subsequent infant feeding practices with gut microbiota and risk of overweight in the first year of life. JAMA Pediatr 2018; 172(7)e181161
[http://dx.doi.org/10.1001/jamapediatrics.2018.1161 ] [PMID: 29868719]
[22]
Sahhaf Ebrahimi F, Homayouni Rad A, Mosen M, Abbasalizadeh F, Tabrizi A, Khalili L. Effect of L. acidophilus and B. lactis on blood glucose in women with gestational diabetes mellitus: a randomized placebo-controlled trial. Diabetol Metab Syndr 2019; 11: 75.
[http://dx.doi.org/10.1186/s13098-019-0471-5 ] [PMID: 31485272]
[23]
Zhang Q, Wu Y, Fei X. Effect of probiotics on glucose metabolism in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials. Medicina (Kaunas) 2016; 52(1): 28-34.
[http://dx.doi.org/10.1016/j.medici.2015.11.008 ] [PMID: 26987497]
[24]
Yao K, Zeng L, He Q, Wang W, Lei J, Zou X. Effect of probiotics on glucose and lipid metabolism in type 2 diabetes mellitus: a meta-analysis of 12 randomized controlled trials. Med Sci Monit 2017; 23: 3044-53.
[http://dx.doi.org/10.12659/MSM.902600 ] [PMID: 28638006]
[25]
Lye H-S, Kuan C-Y, Ewe J-A, Fung WY, Liong MT. The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin, and phytoestrogens. Int J Mol Sci 2009; 10(9): 3755-75.
[http://dx.doi.org/10.3390/ijms10093755 ] [PMID: 19865517]
[26]
Madsen K, Cornish A, Soper P, et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001; 121(3): 580-91.
[http://dx.doi.org/10.1053/gast.2001.27224 ] [PMID: 11522742]
[27]
Cani PD, Neyrinck AM, Fava F, et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007; 50(11): 2374-83.
[http://dx.doi.org/10.1007/s00125-007-0791-0 ] [PMID: 17823788]
[28]
Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 2001; 13(2): 85-94.
[http://dx.doi.org/10.1016/S0898-6568(00)00149-2 ] [PMID: 11257452]
[29]
Uskova MA, Kravchenko LV. Antioxidant properties of lactic acid bacteria--probiotic and yogurt strains. Vopr Pitan 2009; 78(2): 18-23.
[PMID: 19514338]
[30]
Yadav H, Lee J-H, Lloyd J, Walter P, Rane SG. Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. J Biol Chem 2013; 288(35): 25088-97.
[http://dx.doi.org/10.1074/jbc.M113.452516 ] [PMID: 23836895]
[31]
Homayouni-Rad A, Soroush A-R, Khalili L, et al. Diabetes management by probiotics: Current knowledge and future perspective. Int J Vitam Nutr Res 2017; 1: 1-13.
[PMID: 28436760]
[32]
Duca FA, Swartz TD, Sakar Y, Covasa M. Increased oral detection, but decreased intestinal signaling for fats in mice lacking gut microbiota. PLoS One 2012; 7(6)e39748
[http://dx.doi.org/10.1371/journal.pone.0039748 ] [PMID: 22768116]
[33]
Shen J, Obin MS, Zhao L. The gut microbiota, obesity and insulin resistance. Mol Aspects Med 2013; 34(1): 39-58.
[http://dx.doi.org/10.1016/j.mam.2012.11.001 ] [PMID: 23159341]

Rights & Permissions Print Cite
Article Metrics
15
1
© 2024 Bentham Science Publishers | Privacy Policy